ScripsAmerica Inc. (SCRCQ)

[coolerheadsprevail]

financials will only hold more support for when this runs up prior to release.

It’s funny that you mention that because I was just thinking today that the run we have been on, followed by the current pause, is reminiscent of a textbook runup in advance of a bio catalyst (i.e. anticipated release of clinical trial results, upcoming AdComm hearing, upcoming PDUFA vote, etc) where most traders “grab their seats” (i.e. stake out their positions) approx 1-2 months in advance of the news, with the news in this case being the JAN-2015 Main Ave approved orders number, which will provide final confirmation one way or the other whether the new insurance coverage restrictions on compounded Rx’s has any adverse impact on operations and financial results.

But the strange thing, though, is that I’m actually not convinced that the JAN-2015 numbers are really that much of a catalyst. It is a notable milestone, no doubt, as it was one of the obstacles that I had mentioned previously that SCRC needed to overcome. But the reason that I’m not sure how much of an investment catalyst the JAN-2015 numbers will be is because it is the final Phase III rollout of the restrictions that covers simply the largest employers. The NATURE of the Phase III rollout is IDENTICAL to what was rolled out in Phase I last JUL-2014 (voluntary early adopters ) and Phase II last SEP-2014 (small and mid-size employers)… …and from both Phase I and Phase II, we saw that the impact to Main Ave ranged from negligible to non-existent. So if the population of the employee base that is covered/impacted isn’t changing (demographically, anyways), and it is only the size of the employer that is changing, then IMO, logic tells me that we shouldn’t see any impact from the Phase III rollout either.

But perhaps folks are still wanting to wait for confirmation of this via the numbers and believe that more TUTs will buy in once positive confirmation is PR’d? No idea. But seeing how today seemed to show that the slide that we saw yesterday was isolated and not a precursor to a larger bearish trend, one thing is clear: The 22.3M shares that changed hands over the past 5-6 weeks so far seems to be related to folks staking their claim and grabbing their seats in anticipation of something… …what it is in the immediate short-term, I honestly have no idea. Barring an unexpected announcement of something major, I am not aware of any truly major catalyst out there (important milestones, yes, such as the 10K and then the 10Q shortly thereafter, but no true “catalysts”)…

The last month+ has sure been a fun ride, though… …let’s hope it’s not the same ride that we’ve been on several times before over the past 12+ months, though, LOL, as I’m ready to see something different after .20 than the same old retrace…